Optimizing Frontline Therapy in Ovarian Cancer Using PARP Inhibitors: A Video Roundtable

Experts provide their thoughts on key data in breast and gynecologic cancers from the 2022 ASCO Annual Meeting, from Clinical Care Options (CCO)

Joyce O'Shaughnessy, MD Angeles Alvarez Secord, MD, MHSc Physicians: maximum of 1.5 AMA PRA Category 1 Credits™ Released: August 17, 2022 Expired: August 16, 2023

Commentary on novel agents for platinum-resistant ovarian cancer, from Clinical Care Options (CCO)

Kathleen Moore, MD Released: August 11, 2022

Interactive online tool with expert management recommendations for selecting therapy for women with ovarian cancer, from Clinical Care Options (CCO)

Robert L. Coleman, MD, FACOG, FACS Linda R. Duska, MD, MPH Thomas J. Herzog, MD Kathleen Moore, MD David O'Malley, MD Released: August 5, 2022

Gain important nursing insights on the management of patients with gynecologic cancers in this program from Clinical Care Options (CCO)

Courtney Arn, CNP Released: August 2, 2022